Cefepime/Enmetazobactam for Complicated Urinary Tract Infections.
Publication
, Journal Article
Advani, SD; Claeys, K
Published in: JAMA
October 4, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
October 4, 2022
Volume
328
Issue
13
Start / End Page
1299 / 1301
Location
United States
Related Subject Headings
- Urinary Tract Infections
- Triazoles
- Microbial Sensitivity Tests
- Humans
- General & Internal Medicine
- Cefepime
- Bacterial Infections
- Azabicyclo Compounds
- Anti-Bacterial Agents
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Advani, S. D., & Claeys, K. (2022). Cefepime/Enmetazobactam for Complicated Urinary Tract Infections. JAMA, 328(13), 1299–1301. https://doi.org/10.1001/jama.2022.15228
Advani, Sonali D., and Kimberly Claeys. “Cefepime/Enmetazobactam for Complicated Urinary Tract Infections.” JAMA 328, no. 13 (October 4, 2022): 1299–1301. https://doi.org/10.1001/jama.2022.15228.
Advani SD, Claeys K. Cefepime/Enmetazobactam for Complicated Urinary Tract Infections. JAMA. 2022 Oct 4;328(13):1299–301.
Advani, Sonali D., and Kimberly Claeys. “Cefepime/Enmetazobactam for Complicated Urinary Tract Infections.” JAMA, vol. 328, no. 13, Oct. 2022, pp. 1299–301. Pubmed, doi:10.1001/jama.2022.15228.
Advani SD, Claeys K. Cefepime/Enmetazobactam for Complicated Urinary Tract Infections. JAMA. 2022 Oct 4;328(13):1299–1301.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
October 4, 2022
Volume
328
Issue
13
Start / End Page
1299 / 1301
Location
United States
Related Subject Headings
- Urinary Tract Infections
- Triazoles
- Microbial Sensitivity Tests
- Humans
- General & Internal Medicine
- Cefepime
- Bacterial Infections
- Azabicyclo Compounds
- Anti-Bacterial Agents
- 42 Health sciences